JP2022003062A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022003062A5 JP2022003062A5 JP2021155292A JP2021155292A JP2022003062A5 JP 2022003062 A5 JP2022003062 A5 JP 2022003062A5 JP 2021155292 A JP2021155292 A JP 2021155292A JP 2021155292 A JP2021155292 A JP 2021155292A JP 2022003062 A5 JP2022003062 A5 JP 2022003062A5
- Authority
- JP
- Japan
- Prior art keywords
- temperature
- levels
- crystals
- cooled
- reslurrying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021155292A JP7642506B2 (ja) | 2016-09-06 | 2021-09-24 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| JP2024161956A JP2024178291A (ja) | 2016-09-06 | 2024-09-19 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662383822P | 2016-09-06 | 2016-09-06 | |
| JP2019512895A JP7219213B2 (ja) | 2016-09-06 | 2017-09-06 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| JP2021155292A JP7642506B2 (ja) | 2016-09-06 | 2021-09-24 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512895A Division JP7219213B2 (ja) | 2016-09-06 | 2017-09-06 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024161956A Division JP2024178291A (ja) | 2016-09-06 | 2024-09-19 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022003062A JP2022003062A (ja) | 2022-01-11 |
| JP2022003062A5 true JP2022003062A5 (https=) | 2023-04-14 |
| JP7642506B2 JP7642506B2 (ja) | 2025-03-10 |
Family
ID=61562003
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512895A Active JP7219213B2 (ja) | 2016-09-06 | 2017-09-06 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| JP2021155292A Active JP7642506B2 (ja) | 2016-09-06 | 2021-09-24 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| JP2024161956A Pending JP2024178291A (ja) | 2016-09-06 | 2024-09-19 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512895A Active JP7219213B2 (ja) | 2016-09-06 | 2017-09-06 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024161956A Pending JP2024178291A (ja) | 2016-09-06 | 2024-09-19 | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10829443B2 (https=) |
| EP (2) | EP3509582B1 (https=) |
| JP (3) | JP7219213B2 (https=) |
| KR (1) | KR102513800B1 (https=) |
| CN (4) | CN109996540A (https=) |
| CA (1) | CA3036071A1 (https=) |
| DK (1) | DK3509582T3 (https=) |
| ES (1) | ES2970887T3 (https=) |
| FI (1) | FI3509582T3 (https=) |
| MY (1) | MY197630A (https=) |
| PH (1) | PH12019500493A1 (https=) |
| SG (1) | SG11201901998WA (https=) |
| WO (1) | WO2018048871A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
| US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12186296B1 (en) | 2016-07-22 | 2025-01-07 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12478604B1 (en) | 2016-07-22 | 2025-11-25 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| MY197630A (en) | 2016-09-06 | 2023-06-29 | Sk Biopharmaceuticals Co Ltd | Solvate form of (r)-2-amino-3-phenylpropyl carbamate |
| WO2020035769A1 (en) | 2018-08-14 | 2020-02-20 | Glenmark Pharmaceuticals Limited; Glenmark Life Sciences Limited | Process for the preparation of solriamfetol and salt thereof |
| CN113473980A (zh) | 2019-03-01 | 2021-10-01 | 弗拉梅尔爱尔兰有限公司 | 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物 |
| WO2021001457A1 (en) | 2019-07-04 | 2021-01-07 | Sandoz Ag | Crystalline (r)-2-amino-3-phenylpropylcarbamate acid addition salts |
| IT202000013855A1 (it) | 2020-06-10 | 2021-12-10 | Flamma Spa | Un processo per la purificazione del (r)-2-ammino-3-fenilpropil carbammato |
| US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
| US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| AU2023375326A1 (en) * | 2022-11-07 | 2025-05-22 | Axsome Therapeutics | Compositions and methods for treating insomnia |
| WO2024145545A2 (en) * | 2022-12-30 | 2024-07-04 | Axsome Malta Ltd. | Methods of administering solriamfetol to lactating women |
| WO2024194718A1 (en) | 2023-03-22 | 2024-09-26 | Unichem Laboratories Limited | A stable pharmaceutical composition and process for preparing thereof |
| CN121816178A (zh) | 2023-05-30 | 2026-04-07 | 艾克萨姆治疗股份有限公司 | 用于治疗患有与阻塞性睡眠呼吸暂停和白天过度嗜睡相关的认知受损的受试者的认知受损的索安非托 |
| KR20260033050A (ko) | 2023-06-29 | 2026-03-10 | 액섬 테라퓨틱스, 인크. | 수유 여성에게 솔리암페톨을 투여하는 방법 |
| WO2025042959A1 (en) | 2023-08-21 | 2025-02-27 | Axsome Therapeutics, Inc. | Use of solriamfetol for the treatment of orphan diseases |
| WO2025165760A1 (en) * | 2024-01-29 | 2025-08-07 | Axsome Therapeutics, Inc. | Phenylalkylamino carbamates for use in the treatment of attention deficit/hyperactivity disorder |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100197892B1 (ko) * | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
| US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
| KR0173862B1 (ko) | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| KR0173863B1 (ko) | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| DK1140061T3 (da) | 1998-12-23 | 2003-08-25 | Orphan Medical Inc | Mikrobiologisk sunde og stabile opløsninger af gamma-hydroxybutyratsalt til behandling af narcolepsi |
| RU2202607C2 (ru) | 2000-03-03 | 2003-04-20 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" | Штамм бактерий methylophilus methylotrophus - продуцент l-фенилаланина (варианты), способ получения l-фенилаланина |
| US20050080268A1 (en) * | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
| RU2007119648A (ru) | 2004-10-28 | 2008-12-10 | СК Холдингз Ко. | Способ лечения депрессии |
| EP1890684B1 (en) * | 2005-06-08 | 2013-08-14 | SK Biopharmaceuticals Co., Ltd. | Treatment of sleep-wake disorders |
| ES2344469T3 (es) * | 2005-06-22 | 2010-08-27 | Sk Holdings Co., Ltd. | Tratamiento de disfuncion sexual. |
| KR20120098578A (ko) | 2009-06-22 | 2012-09-05 | 에스케이바이오팜 주식회사 | 피로의 치료 또는 예방 방법 |
| US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| EP2496227B1 (en) | 2009-11-06 | 2019-05-22 | SK Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
| BR112012010670A2 (pt) | 2009-11-06 | 2016-04-12 | Sk Biopharmaceuticals Co Ltd | métodos para tratamento de distúrbio de défict de atenção/hiperatividade |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US9050302B2 (en) | 2013-03-01 | 2015-06-09 | Jazz Pharmaceuticals Ireland Limited | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| CA2905457A1 (en) | 2013-03-13 | 2014-10-09 | Aerial Biopharma, Llc | Treatment of cataplexy |
| JP2016530240A (ja) | 2013-07-12 | 2016-09-29 | ジャズ ファーマスティカルズ インターナショナル スリー リミテッドＪａｚｚ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｉｉ Ｌｉｍｉｔｅｄ | 禁煙の促進 |
| CA2917702A1 (en) | 2013-07-18 | 2015-01-22 | Jazz Pharmaceuticals International Iii Limited | Treatment for obesity |
| TWI698415B (zh) | 2014-02-28 | 2020-07-11 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
| JP2019512009A (ja) | 2016-02-16 | 2019-05-09 | ザ・ユニバーシティ・オブ・クイーンズランド | スルホニルウレアおよび関連化合物ならびにこれらの利用 |
| MY197630A (en) * | 2016-09-06 | 2023-06-29 | Sk Biopharmaceuticals Co Ltd | Solvate form of (r)-2-amino-3-phenylpropyl carbamate |
| KR101950254B1 (ko) | 2016-09-21 | 2019-02-20 | 유상신 | 차량탑승자의 부재를 감지하는 지능형 카시트 |
| WO2020035769A1 (en) * | 2018-08-14 | 2020-02-20 | Glenmark Pharmaceuticals Limited; Glenmark Life Sciences Limited | Process for the preparation of solriamfetol and salt thereof |
-
2017
- 2017-09-06 MY MYPI2019001180A patent/MY197630A/en unknown
- 2017-09-06 CN CN201780065192.6A patent/CN109996540A/zh active Pending
- 2017-09-06 EP EP17849432.4A patent/EP3509582B1/en active Active
- 2017-09-06 US US16/331,069 patent/US10829443B2/en active Active
- 2017-09-06 ES ES17849432T patent/ES2970887T3/es active Active
- 2017-09-06 CN CN202511369602.9A patent/CN121202730A/zh active Pending
- 2017-09-06 SG SG11201901998WA patent/SG11201901998WA/en unknown
- 2017-09-06 DK DK17849432.4T patent/DK3509582T3/da active
- 2017-09-06 WO PCT/US2017/050233 patent/WO2018048871A1/en not_active Ceased
- 2017-09-06 FI FIEP17849432.4T patent/FI3509582T3/fi active
- 2017-09-06 CN CN202511369712.5A patent/CN121202731A/zh active Pending
- 2017-09-06 JP JP2019512895A patent/JP7219213B2/ja active Active
- 2017-09-06 CA CA3036071A patent/CA3036071A1/en not_active Abandoned
- 2017-09-06 CN CN202510706413.XA patent/CN120574152A/zh active Pending
- 2017-09-06 KR KR1020197011279A patent/KR102513800B1/ko active Active
- 2017-09-06 EP EP23218015.8A patent/EP4364794A3/en active Pending
-
2019
- 2019-03-06 PH PH12019500493A patent/PH12019500493A1/en unknown
-
2020
- 2020-11-06 US US17/091,222 patent/US11560354B2/en active Active
-
2021
- 2021-09-24 JP JP2021155292A patent/JP7642506B2/ja active Active
-
2022
- 2022-12-14 US US18/066,000 patent/US12384743B2/en active Active
-
2024
- 2024-09-19 JP JP2024161956A patent/JP2024178291A/ja active Pending
-
2025
- 2025-07-11 US US19/266,767 patent/US20250340509A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022003062A5 (https=) | ||
| AU2011214423B2 (en) | Method for the preparation of rivaroxaban | |
| JP2018193405A5 (https=) | ||
| JP2018531963A5 (https=) | ||
| JP2015532645A5 (https=) | ||
| RU2593752C1 (ru) | Соединения, пригодные для синтеза бензамидных соединений | |
| JP2019529549A5 (https=) | ||
| JP2013541592A5 (https=) | ||
| JP2016121177A5 (https=) | ||
| JP2012500819A5 (https=) | ||
| RU2016118796A (ru) | Новая кристаллическая форма 2-{ 3-[2-(1-{ [3, 5-бис(дифторметил)-1н-пиразол-1-ил]ацетил} пиперидин-4-ил)-1, 3-тиазол-4-ил]-4, 5-дигидро-1, 2-оксазол-5-ил} -3-хлорфенилметансульфоната | |
| JP2009179634A5 (https=) | ||
| CN106029641B (zh) | 1,1-二取代肼化合物的制造方法 | |
| CN101768150B (zh) | 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法 | |
| JP2016510767A5 (https=) | ||
| JP2012233173A5 (https=) | ||
| CN103443084A (zh) | 制备苯达莫司汀的方法 | |
| AR081267A1 (es) | Procedimiento de obtencion de la forma cristalina a del febuxostat | |
| JP2016501179A5 (https=) | ||
| CN107827886B (zh) | 一种高纯度阿维巴坦的精制制备工艺 | |
| JP2013528577A5 (https=) | ||
| JP2019522650A5 (https=) | ||
| CN104031068A (zh) | 一锅法制备盐酸头孢替安酯的方法 | |
| JP2019019200A5 (https=) | ||
| KR101811123B1 (ko) | 신규의 모르폴린 이인산염 및 이를 이용한 고순도 리바록사반의 제조방법 |